Medpace

medpace.com · Cincinnati, United States of America

Medpace is a global clinical research organization that provides full-service Phase I–IV clinical development services to pharmaceutical, biotechnology, and medical device companies. It manages clinical trials across therapeutic areas, offering study design, regulatory affairs, site management, data management, and biostatistics to support drug and device approvals. Medpace generates revenue through contracted clinical research and related consulting services for life sciences sponsors.

  • IT Consulting & Implementation
Revenue
$1.6B
Employees
5,500
Founded
1992
Headquarters
Cincinnati, United States of America

What 53 Arbolus experts think of Medpace

NPS scores range from 1 to 10 with a mean skewed toward 8-10 among high-spend, long-tenure customers. Renewal intent is positive for most top spenders, while a sizable minority of users remain unsure. Stickiness is demonstrated by the majority (>75%) of customers being live for more than a year, with very few in onboarding or disengagement phases. The main sentiment theme is satisfaction among high-value, established customers, while uncertainty in renewal persists at the low and mid-spend tiers.Overall Customer Sentiment: Positive

Who reviewed Medpace

Total customers 53 51 current · 2 former
Reviews growth +19 in six months
Seniority of respondents
  • C-Suite 57% (30)
  • Director 30% (16)
  • Manager 13% (7)
Operations Leader Director NPS 4
Strategy Leader C-Suite NPS 8 Undecided
Other Analyst C-Suite NPS 8 Undecided

Employer names and spend open once the report publishes.

Tell us when the Medpace report publishes.

We'll email you once the full customer report is ready, with employer names, spend and every written answer. No account needed.

Notify me

Sentiment

5 Net Promoter Score, from 53 scored reviews
  • Promoters 15
  • Passives 26
  • Detractors 12

Cumulative NPS by month

+0 over 6 months
  • Apr 7
  • Jun 7
  • Jul 7
  • Aug 7
  • Sep 7
  • Oct 7

Net Promoter Score across 2 reviews, accumulated up to each month. Category median 16 across 2 companies.

Written answers and themes publish with the full report.

Renewal intent

Plan to renew 32%
  • Will renew 11
  • Undecided 22
  • Not renewing 1

Plan to renew, by seniority

  • C-Suite 27% 22 answers
  • Director 36% 11 answers
  • Manager 100% 1 answer
  • 8.4/10 Average score from customers who will renew
  • 6.8/10 Average score from undecided customers
  • 6/10 Average score from customers not renewing

Top alternatives

Most weighed by Medpace customers

For people who use Medpace

Do you use Medpace at work?

Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.

  • 53 customers of Medpace have already contributed
Share your experience

Takes a few minutes. Your identity stays anonymous.